I would happily trade the pellet guns for some .22
Post# of 148280
The problem is the story, the recent run up was a perfect story stock, the reality of the actual story is setting in.
I do think we have reached some level of fair value based on the story we know. In my mind that is $2-3 for HIV and cancer (looks good from a galloping horse so far) with a small premium for the potential (today) of covid.